CAD From Donor Hearts Warrants Follow-Up, Vigilant Risk Factor Control

The biggest unknown is whether this would increase the likelihood of more allograft vasculopathy down the line.

Related Keywords

San Francisco ,California ,United States ,Spain ,Spanish ,Los Angeles ,Rushi Parikh ,David Couto ,Richard Cheng ,Journal Of The American College Cardiology ,Md University Of California ,David Couto Mall ,Hospital Universitario ,American College ,